Citalopram
NDC Package 67046-112-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Citalopram is hypertensionMetoprolol tartrate tablets are indicated for the treatment of hypertension. Marketed by Contract Pharmacy Services-pa, this product is identified by NDC 67046-112 and is authorized under FDA application ANDA077031.

Identification & Billing

NDC Package Code
67046-112-30
Package Description
30 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
67046-112
11-Digit Billing Format
67046011230
RxNorm Crosswalk
RxCUI: 866514 - metoprolol tartrate 50 MG Oral Tablet

Clinical Specifications

Proprietary Name
Citalopram
Dosage Form
-
Usage Information
HypertensionMetoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents.Angina PectorisMetoprolol tartrate tablets are indicated in the long-term treatment of angina pectoris.Myocardial InfarctionMetoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol. Oral Metoprolol tartrate tablets therapy can be initiated after intravenous metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event. (See DOSAGE AND ADMINISTRATION,  CONTRAINDICATIONS, and WARNINGS).

Regulatory & Marketing

Labeler Name
Contract Pharmacy Services-pa
FDA Application #
ANDA077031
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-06-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67046-112-30 identifies a specific commercial package of 30 tablet, film coated in 1 blister pack of Citalopram, labeled by Contract Pharmacy Services-pa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Contract Pharmacy Services-pa on April 06, 2010. The current certification is valid through December 31, 2017.

How is this Contract Pharmacy Services-pa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67046011230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67046-112-30
11-Digit CMS (5-4-2)
67046-0112-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.